Sign in to follow this  
Followers 0
janey

Cancer drug shows promise for treating scleroderma

1 post in this topic

Cancer drug shows promise for treating scleroderma.

While the drug's efficacy must be demonstrated in a Phase III trial, the gold standard for testing a drug, researchers are optimistic that Gleevecâ„¢ (imatinib) could potentially be a weapon against the chronic connective tissue disease for which a treatment has remained elusive. Phyllis Fisher. EurekAlert! 3/28/11. (Also see: Clinical Trials - Gleevec)

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Janey Willis

ISN Support Specialist

(Retired) ISN Assistant Webmaster

(Retired) ISN News Director

(Retired) ISN Technical Writer for Training Manuals

International Scleroderma Network (ISN)

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!


Register a new account

Sign in

Already have an account? Sign in here.


Sign In Now
Sign in to follow this  
Followers 0